Cannabinoid CB1 and CB2 Receptor Ligand Specificity and the Development of CB2-Selective Agonists

作者
John C. Ashton,Jason Wright,John M. McPartland,Joel D. A. Tyndall
出处
期刊:Current Medicinal Chemistry [Bentham Science Publishers]
卷期号:15 (14): 1428-1443 被引量:92
标识
DOI:10.2174/092986708784567716
摘要

Cannabinoids in current use such as nabilone activate both CB1 and CB2 receptors. Selective CB2 activation may provide some of the therapeutic effects of cannabinoids, such as their immuno-modulatory properties, without the psychoactive effects of CB1 activation. Therefore, cannabinoid CB2 receptors represent an attractive target for drug development. However, selective and potent CB2 agonists remain in development. CB1 and CB2 differ considerably in their amino acid sequence and tertiary structures. Therefore, clinical development of potent and selective CB2 agonists is probable. Mutational and ligand binding studies, functional mapping, and computer modelling have revealed key residues and domains in cannabinoid receptors that are involved in agonist and antagonist binding to CB1 and CB2. In addition, CB2 has undergone more rapid evolution, and results for ligand binding and efficacy cannot be automatically extrapolated from rat or mouse CB2 to human. Furthermore, loss of CB1 affinity is a crucial property for CB2-selective ligands, and although rat CB1 is 97% homologous with human CB1, critical differences do exist, with potential for further exploitation in drug design. In this paper we briefly review previous cannabinoid receptor models and mutation/binding studies. We also review binding affinity ratios with respect to CB1 and CB2. We then employ our own models to illustrate key cannabinoid receptor residues and binding subdomains that are involved in these differences in binding affinities and discuss how these might be exploited in the development of CB2 specific ligands. Published reports for species specific binding affinities for CB2 are scarce, and we argue that this needs to be corrected prior to the progression of CB2 agonists from pre-clinical to clinical research.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
2秒前
TGU发布了新的文献求助10
3秒前
Hello的应助被开心德地采纳,获得10
3秒前
CipherSage的应助被山野的雾采纳,获得10
6秒前
小二郎的应助被开心德地采纳,获得30
7秒前
kelly发布了新的文献求助10
7秒前
超级无敌发布了新的文献求助10
7秒前
8秒前
搜集达人的应助被开心德地采纳,获得10
10秒前
11秒前
科研通AI65的应助被tianxings采纳,获得10
11秒前
小古发布了新的文献求助10
12秒前
12秒前
kelly完成签到,获得积分10
13秒前
砍柴少年发布了新的文献求助10
13秒前
CipherSage的应助被liu采纳,获得10
13秒前
鲤鱼天奇完成签到,获得积分20
13秒前
molihuakai的应助被Yxianzi采纳,获得10
13秒前
ket的应助被大兔米菲采纳,获得10
13秒前
古娜娜黑暗之神完成签到,获得积分10
14秒前
14秒前
挚友发布了新的文献求助30
14秒前
祎辰完成签到 ,获得积分10
14秒前
科研通AI6.3的应助被LIUDAN采纳,获得10
14秒前
科研通AI2S的应助被开心德地采纳,获得10
14秒前
w_完成签到,获得积分10
15秒前
7Wen发布了新的文献求助10
15秒前
学霸业的应助被yangllln采纳,获得10
16秒前
taoshiren完成签到,获得积分10
16秒前
科研通AI2S的应助被谭小谭采纳,获得10
17秒前
17秒前
山野的雾发布了新的文献求助10
18秒前
fantasy的应助被大兔米菲采纳,获得10
18秒前
19秒前
20秒前
20秒前
21秒前
充电宝的应助被学术垃圾采纳,获得10
21秒前
香蕉觅云的应助被老实的若风采纳,获得10
21秒前
科研全白完成签到 ,获得积分10
22秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8189302
求助须知:如何正确求助?哪些是违规求助? 9576666
关于积分的说明 21849295
捐赠科研通 7787245
什么是DOI,文献DOI怎么找? 3435521
关于科研通互助平台的介绍 2559748
邀请新用户注册赠送积分活动 2482509